Introducing the first US FDA-approved distributable comprehensive genomic profiling (CGP) in vitro diagnostic (IVD) with pan-cancer companion diagnostic (CDx) claims! This represents a major milestone for Illumina and our clinical Oncology product portfolio. Please share this exciting news and help our customers reap the benefits of a streamlined onboarding process and greater access to reimbursement with an IVD!
53 others have already shared this!
TruSight Oncology Comprehensive is now US FDA approved - the first distributable comprehensive genomic profiling IVD kit with pan-cancer companion diagnostic (CDx) claims! To learn more about TruSight Oncology Comprehensive: https://bit.ly/4edYeoH
TruSight Oncology Comprehensive is now US FDA approved - the first distributable comprehensive genomic profiling IVD kit with pan-cancer companion diagnostic (CDx) claims! To learn more about TruSight Oncology Comprehensive: https://bit.ly/4edYeoH